Creative Arts II Study
NCT03994718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2021-06-28
Summary
The purpose of this study is to determine the impact of music, visual art, or creative writing on quality of life measures for epilepsy patients.
Conditions
Interventions
- OTHER
-
Music intervention
The music therapist will work with subjects for up to 60 minutes each session.
- OTHER
-
Visual arts intervention
The visual artist will work with subjects for up to 60 minutes each session.
- OTHER
-
Creative writing intervention
The creative writer will work with subjects for up to 60 minutes each session.
Sponsors & Collaborators
-
National Endowment for the Arts, United States
collaborator FED -
Dartmouth-Hitchcock Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-30
- Primary Completion
- 2021-04-01
- Completion
- 2021-04-01
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
NCT00744731 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
NCT00740623 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
NCT03059329 ·Status: COMPLETED
-
Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey)
NCT02925663 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
NCT03059381 ·Status: COMPLETED
-
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
NCT06769659 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects
NCT01918735 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Autologous MSC Infusion to Treat Epilepsy
NCT02497443 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures
NCT06657378 ·Status: RECRUITING
-
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
NCT00280059 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Drug Resistant Epilepsy: Clinical and Genetic Study
NCT04166305 ·Status: UNKNOWN
-
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
NCT03934268 ·Status: UNKNOWN
-
Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
NCT06836687 ·Status: RECRUITING
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Prevalence of Headache in Epileptic Patients
NCT00277368 ·Status: COMPLETED
-
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
NCT03208660 ·Status: COMPLETED
-
Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
NCT05671575 ·Status: UNKNOWN
-
A Study of GWP42006 in People With Focal Seizures - Part A
NCT02369471 ·Status: COMPLETED ·Phase: PHASE2
-
Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
NCT06794606 ·Status: RECRUITING
-
Study of Cannabidiol for Drug-Resistant Epilepsies
NCT03014440 ·Status: NO_LONGER_AVAILABLE
-
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
NCT05135091 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
NCT06422923 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy
NCT04230044 ·Status: COMPLETED